The endocannabinoid system
Homeostasis & signalling
Your body already has a system for balance.
The endocannabinoid system — or ECS — is a biological regulatory network present throughout the body. It participates in maintaining homeostasis: the body's continuous process of adjusting and adapting to internal and external change.
As we sleep, experience stress, move, recover, eat, exercise or respond to discomfort and inflammation, the body is constantly making adjustments to maintain equilibrium.
The endocannabinoid system is part of that conversation.
A regulatory network, not a single receptor.
The endocannabinoid system isn't a single receptor or pathway. It is a network made up of endocannabinoids produced naturally by the body, receptors that respond to them, and enzymes that create and break down these signalling molecules.
Together, they form a communication system that helps the body continuously respond and adapt.
And this is where CBD becomes interesting.
CBD doesn't simply “switch on” the endocannabinoid system. Its relationship with the ECS is much more nuanced. CBD can influence endocannabinoid signalling through several mechanisms, including effects on the availability and metabolism of the body's own endocannabinoids.
This is why CBD is best understood not as a simple cannabinoid-receptor activator, but as a modulator of an entire regulatory network.
One molecule. Many pathways.
CBD's pharmacology doesn't stop at the endocannabinoid system. Researchers have identified interactions with a remarkably broad range of receptors, ion channels, enzymes, transport systems and signalling pathways throughout the body.
The pathways below are some of the most commonly discussed and studied examples — but they represent only part of CBD's much broader pharmacology.
Scientific research continues to investigate many additional molecular targets and mechanisms through which cannabidiol may influence biological signalling.
These are selected pathways — not the whole picture.
CBD interacts with serotonin signalling, including the 5-HT1A receptor — one of the pathways involved in mood, stress responses and emotional regulation.
CBD interacts with TRPV1, an ion channel involved in how the nervous system processes heat, inflammation and painful stimuli.
CBD can influence adenosine signalling, a system involved in inflammatory responses, neuronal activity, blood flow and cellular energy regulation.
CBD is also studied for its influence on neuronal excitability — the delicate balance between excitatory and inhibitory signalling in the nervous system.
Cannabidiol is more than a subject of laboratory research.
A purified pharmaceutical form of cannabidiol is already used clinically for specific severe seizure disorders.
This is particularly relevant when looking at neuronal signalling: it demonstrates that purified cannabidiol can exert biologically meaningful effects within the human nervous system.
The pharmaceutical context is very different from everyday wellness use, but its existence provides an important bridge between molecular research and established clinical pharmacology.
And there is still much more to understand.
Serotonin, TRPV1, adenosine and neuronal excitability are useful examples because they help illustrate the breadth of CBD's pharmacology. But they are not an exhaustive list.
Cannabidiol is being investigated across numerous additional receptors, enzymes, ion channels and signalling mechanisms. The scientific picture continues to evolve as researchers better understand how one molecule can influence such a diverse biological network.